IN2014DN07091A - - Google Patents
Info
- Publication number
- IN2014DN07091A IN2014DN07091A IN7091DEN2014A IN2014DN07091A IN 2014DN07091 A IN2014DN07091 A IN 2014DN07091A IN 7091DEN2014 A IN7091DEN2014 A IN 7091DEN2014A IN 2014DN07091 A IN2014DN07091 A IN 2014DN07091A
- Authority
- IN
- India
- Prior art keywords
- sodium
- hydroxysafflor yellow
- hydroxysafflor
- yellow
- safflower
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310048476.8A CN103980239B (zh) | 2013-02-07 | 2013-02-07 | 羟基红花黄色素a钠及其生产方法和用途 |
| PCT/CN2013/000686 WO2014121424A1 (zh) | 2013-02-07 | 2013-06-08 | 羟基红花黄色素a钠及其生产方法和制药用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07091A true IN2014DN07091A (ja) | 2015-04-24 |
Family
ID=51272434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7091DEN2014 IN2014DN07091A (ja) | 2013-02-07 | 2013-06-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9243019B2 (ja) |
| EP (1) | EP2829547B1 (ja) |
| JP (1) | JP6133415B2 (ja) |
| KR (1) | KR101801700B1 (ja) |
| CN (2) | CN103980239B (ja) |
| IN (1) | IN2014DN07091A (ja) |
| WO (1) | WO2014121424A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104230864A (zh) * | 2013-06-08 | 2014-12-24 | 浙江永宁药业股份有限公司 | 新的羟基红花黄色素a二价药用盐及其制备方法和用途 |
| CN103980239B (zh) * | 2013-02-07 | 2016-04-13 | 浙江永宁药业股份有限公司 | 羟基红花黄色素a钠及其生产方法和用途 |
| IN2014DN10592A (ja) * | 2013-02-07 | 2015-09-11 | Zhejiang Yongning Pharmaceutical Co Ltd | |
| CN105901923B (zh) * | 2016-06-03 | 2017-10-24 | 佛山市迪赛纳科技有限公司 | 升降机构及包含升降机构的升降工作台和工作台升降方法 |
| CN106214719B (zh) * | 2016-08-31 | 2020-01-24 | 江西桔王药业有限公司 | 一种舒胸颗粒的制备方法 |
| CN108392486B (zh) * | 2018-01-23 | 2020-01-03 | 滨州医学院 | 羟基红花黄色素b在制备防治心肌缺血再灌注损伤的药物中的应用 |
| CN113504199A (zh) * | 2021-06-29 | 2021-10-15 | 苏州泽达兴邦医药科技有限公司 | 一种基于数据挖掘的红花提取液树脂纯化过程质量控制方法 |
| CN113816933B (zh) * | 2021-10-14 | 2024-02-09 | 北京悦康科创医药科技股份有限公司 | 一种羟基红花黄色素a的制备方法 |
| CN113995729B (zh) * | 2021-10-22 | 2022-11-18 | 北京悦康科创医药科技股份有限公司 | 羟基红花黄色素a口服半固体胶囊及其制备方法和应用 |
| CN114098074A (zh) * | 2021-11-09 | 2022-03-01 | 江南大学 | 羟基红花黄色素a在增强耐力中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4510230B2 (ja) * | 2000-05-26 | 2010-07-21 | 三栄源エフ・エフ・アイ株式会社 | 脱臭ベニバナ黄色素 |
| CN1284794C (zh) | 2002-08-17 | 2006-11-15 | 李盛学 | 羟基红花黄色素a的制备方法 |
| CN100418522C (zh) * | 2004-01-08 | 2008-09-17 | 山东瑞阳制药有限公司 | 大剂量的羟基红花黄色素a或其可药用盐的制药应用 |
| JP2007063130A (ja) * | 2004-03-31 | 2007-03-15 | Kureha Corp | 抗糖尿病用組成物 |
| CN1935176B (zh) * | 2005-09-23 | 2010-07-14 | 北京星昊医药股份有限公司 | 含有总红花黄色素的红花提取物的制备方法 |
| CN100427107C (zh) * | 2006-06-24 | 2008-10-22 | 太原华卫药业有限公司 | 一种红花注射液制备方法 |
| CN101195647B (zh) * | 2006-12-06 | 2010-08-18 | 山西华辉凯德制药有限公司 | 羟基红花黄色素a及其制备方法和应用 |
| CN101879155B (zh) * | 2007-12-04 | 2011-12-21 | 哈药集团中药二厂 | 注射用丹红的制备方法 |
| CN101168539B (zh) * | 2007-12-04 | 2011-01-19 | 哈药集团中药二厂 | 丹酚酸b的提取方法 |
| CN101215307B (zh) | 2008-01-08 | 2010-11-10 | 山西大学 | 一种羟基红花黄色素a的制备方法 |
| CN101640392A (zh) * | 2009-07-15 | 2010-02-03 | 武汉科瑞德电力科技有限公司 | 35kV配电线路带电作业断引流线的作业方法 |
| CN102675379B (zh) | 2011-03-15 | 2015-08-19 | 河北以岭医药研究院有限公司 | 一种从红花中提取精制羟基红花黄色素a的方法 |
| CN102702150B (zh) * | 2012-06-19 | 2014-09-17 | 浙江永宁药业股份有限公司 | 一种羟基红花黄色素a的制备方法和应用 |
| CN103980239B (zh) * | 2013-02-07 | 2016-04-13 | 浙江永宁药业股份有限公司 | 羟基红花黄色素a钠及其生产方法和用途 |
-
2013
- 2013-02-07 CN CN201310048476.8A patent/CN103980239B/zh active Active
- 2013-06-08 CN CN201380042130.5A patent/CN104603143B/zh active Active
- 2013-06-08 IN IN7091DEN2014 patent/IN2014DN07091A/en unknown
- 2013-06-08 KR KR1020147024728A patent/KR101801700B1/ko active IP Right Grant
- 2013-06-08 EP EP13874429.7A patent/EP2829547B1/en active Active
- 2013-06-08 JP JP2015517584A patent/JP6133415B2/ja active Active
- 2013-06-08 WO PCT/CN2013/000686 patent/WO2014121424A1/zh active Application Filing
- 2013-06-08 US US14/383,557 patent/US9243019B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2829547A1 (en) | 2015-01-28 |
| KR101801700B1 (ko) | 2017-11-27 |
| KR20150035491A (ko) | 2015-04-06 |
| US9243019B2 (en) | 2016-01-26 |
| CN104603143A (zh) | 2015-05-06 |
| CN103980239A (zh) | 2014-08-13 |
| CN103980239B (zh) | 2016-04-13 |
| CN104603143B (zh) | 2016-12-14 |
| JP2015525232A (ja) | 2015-09-03 |
| JP6133415B2 (ja) | 2017-05-24 |
| EP2829547B1 (en) | 2018-04-04 |
| WO2014121424A1 (zh) | 2014-08-14 |
| EP2829547A4 (en) | 2015-11-18 |
| US20150025030A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07091A (ja) | ||
| TN2015000026A1 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| IL257963B (en) | Compounds for the treatment of diseases related to the production of mitochondrial reactive oxygen species (ros). | |
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| EA201270824A1 (ru) | Соединения для уменьшения продукции бета-амилоида | |
| EA201391029A1 (ru) | Производные оксазина и их применение при лечении неврологических нарушений | |
| EA201291348A1 (ru) | Активаторы растворимой гуанилатциклазы | |
| EA201491854A1 (ru) | Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств | |
| MX355330B (es) | Formas cristalinas de compuestos terapeuticos y sus usos. | |
| MY176246A (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
| EA201600096A1 (ru) | Бензил-1н-пиразол[3,4-b]пиридины и их применение | |
| HRP20211046T1 (hr) | Upotreba derivata benzimidazola kod noćnog proboja kiseline | |
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| EP3285771A4 (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| HRP20201187T1 (hr) | Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1 | |
| EP3256208A4 (en) | Monitoring of intrinsic heart rate recovery to improve stimulation therapy for heart failure patients | |
| IL269127A (en) | Derivatives of desmetylantol triton for the treatment of diseases related to the generation of reactive oxygen species (ROS) of mitochondrial origin | |
| EA201591704A1 (ru) | Новые устойчивые соли пентадекапептида, способ их получения, их применение в производстве фармацевтических составов и их применение в терапии | |
| MX357888B (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
| MX2017001433A (es) | Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana. | |
| MX2017015202A (es) | Formulaciones liquidas de celecoxib para administracion oral. | |
| UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| WO2015031198A3 (en) | Bendamustine pharmaceutical compositions | |
| MX2015007885A (es) | Compuestos farmaceuticos. |